Replay available

iRadimed Corporation (IRMD) Q4 2025 Earnings Call

iRadimed Corporation (NASDAQ: IRMD) Q4 2025 earnings conference call, held 2026-02-10. Replay captured from the company's public earnings webcast.

Tue, February 10, 2026 at 11:00 AMendedReplay
iRadimed Corporation (IRMD) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Roger Sussi

President and Chief Executive Officer

Jack Glenn

Chief Financial Officer

Frank Takinen

Analyst, Lake Street Capital Markets

Kyle Bowser

Analyst, Ross Capital Partners

Replay transcript excerpt

Welcome to the ARADIMED Corporation Fourth Quarter 2025 Financial Results Conference Call. All participants are current in listen-only mode. At the end of the call, we will conduct a question-and-answer session. This call is being recorded today, February 10, 2026, and contains time-sensitive, accurate information that is valid only for today. Earlier, ARADIMED released its financial results for the fourth quarter of 2025. A copy of this press release announcing the company's earnings is available under the heading News on the website at IRDMed.com. A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8K and can be found at SEC.gov. This call is being broadcast live on the company's website at irdmed.com, and a replay will be available there for the next 90 days. Some of the information in today's session will constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements focus on future performance results, plans, and events, and may include the company's expected future results. Aradiomed reminds you that future results may differ materially from these forward-looking statements due to several risk factors. For a description of the relevant risks and uncertainties that may affect the company's business, please see the risk factor section of the company's most recent report filed with the Securities and Exchange Commission, which may be obtained free from the SEC's website at sec.gov. I want to turn the call over to Roger Sussi, President and Chief Executive Officer of Aradimet Corporation. Mr. Sussi. Thank you, and good morning. Thank you all for joining us on today's call. And once again, we have some exciting performance to announce. I'm very ...

More from Iradimed Corporation